Patrick Griffin soars in as ImmusanT CMO
This article was originally published in Scrip
Privately-held biotech ImmusanT has hired Dr Patrick Griffin chief medical officer and senior vice-president of development. Dr Griffin joins ImmusanT from Sanofi's immuno-inflammation therapeutic strategy unit where he was most recently head of external innovation. He originally joined Sanofi in 2005 as senior director of clinical development.